, a specialty immune globulin business that develops, manufactures and intends to advertise plasma-centered biologics for the prevention and treatment of specific infectious diseases, announced that the first patient signed up for the pivotal Stage III clinical study of its RI-002 offers been dosed. This study is designed to measure the efficacy and protection of RI-002 as a novel immune globulin for the treating patients who have problems with Primary Immune Deficiency Diseases . Related StoriesMobile diagnosis device in reducing unneeded antibiotics prescribingOJ Bio at Medica 2015 – Point of Care diagnostics' role in reducing antibiotics prescribingCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr Chakravarthy The trial has been conducted in accordance with the U.S.If you’re on Twitter, you know that 50 Cent dropped from 214 to a scrawny 160 to seem sickly for his part in ‘Things BREAK APART. He regularly posted twitpics of himself getting thinner and thinner. And did you know that Renee Zellweger gained nearly 30 pounds to perform the title part in Bridget Jones’s Diary. And there’s Christian Bale, who lost 63 pounds to play the lead in The Machinist. See 10 most shocking celebrity weight changes.
40,000 Drop-Side Cribs Recalled for Safety Risks Consumer basic safety regulators ordered the recall Friday greater than 40,000 cribs after basic safety problems were raised by 6 child injuries.